Acción TJBH TENGJUN BIOTECHNOLOGY CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Tengjun Biotechnology Corp. Other OTC

Acciones

TJBH

US88035C1071

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes
Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes
Tengjun Biotechnology Corp. Announces Board Changes
Tengjun Biotechnology : Change in Certifying Accountants - Form 8-K
Tengjun Biotechnology Corp. Announces CEO Changes
Tengjun Biotechnology Corp. Announces CFO Changes
Tengjun Biotechnology Corp. Announces Board Changes
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tengjun Biotechnology Corp. (TJBH) on Behalf of Investors
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Tengjun Biotechnology Corp. Investors to Inquire About Securities Class Action Investigation – TJBH
Tengjun Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tengjun Biotechnology : Non-Reliance on Previously Issued Financial Report - Form 8-K
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as the Interim Chief Executive Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as Interim Chief Financial Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as A Member of the Board
Tengjun Biotechnology Corp. Announces Demise of Xianchang Ma, Chief Executive Officer
Tengjun Biotechnology Corp. Announces Xianchang Ma, Chief Financial Officer, Passed Away
Tengjun Biotechnology Corp. Announces demise of Xianchang Ma, Director
Tengjun Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
TENGJUN BIOTECHNOLOGY CORP. : Other Events (form 8-K)
TENGJUN BIOTECHNOLOGY CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción TJBH
  4. Acción TJBH
  5. Noticias Tengjun Biotechnology Corp.
  6. Otros idiomas